---
title: "Liquidia Corporation（NASDAQ:LQDA）2025 年第四季度財報電話會議記錄"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/278265526.md"
description: "Liquidia Corporation（納斯達克代碼：LQDA）公佈了 2025 年第四季度的財報，超出預期，每股收益為 0.15 美元，而預期為 0.08 美元。財報電話會議於 2026 年 3 月 5 日舉行，公司提供了財務更新，並討論了 2025 年的整體表現"
datetime: "2026-03-08T12:23:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278265526.md)
  - [en](https://longbridge.com/en/news/278265526.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278265526.md)
---

# Liquidia Corporation（NASDAQ:LQDA）2025 年第四季度財報電話會議記錄

Liquidia Corporation (NASDAQ:LQDA) Q4 2025 Earnings Call Transcript March 5, 2026 Liquidia Corporation beats earnings expectations. Reported EPS is $0.15, expectations were $0.08. Operator: Good morning, and welcome to the Liquidia Corporation Full Year 2025 Financial Results and Corporate Update Conference Call. My name is Josh, and I will be your operator today. A question \[…\]

### 相關股票

- [BBH.US](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [BIB.US](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [XLV.US](https://longbridge.com/zh-HK/quote/XLV.US.md)
- [PBE.US](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [VHT.US](https://longbridge.com/zh-HK/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/zh-HK/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [LQDA.US](https://longbridge.com/zh-HK/quote/LQDA.US.md)
- [SBIO.US](https://longbridge.com/zh-HK/quote/SBIO.US.md)

## 相關資訊與研究

- [鉅亨速報 - Factset 最新調查：Krystal Biotech Inc(KRYS-US) EPS 預估下修至 7.55 元，預估目標價為 323.00 元](https://longbridge.com/zh-HK/news/282570027.md)
- [雙雙入選 2026 SGO 口頭報告：蘆康沙妥珠單抗 (sac-TMT) 兩項婦科腫瘤研究成果發佈](https://longbridge.com/zh-HK/news/282607157.md)
- [藥廠 AI 合作潮！諾和諾德攜手 OpenAI 股價走揚](https://longbridge.com/zh-HK/news/282755292.md)
- [諾和諾德夥 OpenAI 研發藥物 AI 分析數據 識別具潛力候選藥](https://longbridge.com/zh-HK/news/282661383.md)
- [諾和諾德與 OpenAI 攜手，以 AI 加速開發肥胖與代謝藥物](https://longbridge.com/zh-HK/news/282666368.md)